x

Posted 23 September, 2022

Nuwellis, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:NUWE in a 8-K filed on 23 September, 2022.


  On September 22, 2022, the Board of Directors of the Company (the "Board") appointed Nestor Jaramillo, Jr., the Company's President and Chief Executive Officer, beginning on the Separation Date, as the interim Chief Financial Officer and the interim Principal Financial Officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Nuwellis, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Market Cap
$3.39M
View Company Details
Relevant filing section
Item 5.02 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Resignation of Chief Financial Officer


On September 19, 2022, George Montague notified Nuwellis, Inc., a Delaware corporation (the "Company") of his decision to resign as the Chief Financial Officer of the Company. Mr. Montague's last date with the Company is expected to be on or about October 20, 2022 (the "Separation Date"). Mr. Montague's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or procedures. The Company has commenced a formal search process for the position of Chief Financial Officer for the Company.


Appointment of Interim Chief Financial Officer and Principal Accounting Officer


On September 22, 2022, the Board of Directors of the Company (the "Board") appointed Nestor Jaramillo, Jr., the Company's President and Chief Executive Officer, beginning on the Separation Date, as the interim Chief Financial Officer and the interim Principal Financial Officer. Mr. Jaramillo, age 65, has served as the Company's President and Chief Executive Officer since January 2021.


There is no arrangement or understanding between Mr. Jaramillo and any other person pursuant to which Mr. Jaramillo was selected as an officer. Mr. Jaramillo has no family relationships with any of the Company's directors or executive officers. There are no transactions and no proposed transactions between Mr. Jaramillo and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.


On September 22, 2022, the Board appointed Rob Scott as the Company's interim Principal Accounting Officer, beginning on the Separation Date. Mr. Scott, age 43, joined the Company in January of 2014 and has served as the Company's Senior Director, Financial Planning & Analysis since June 2022. Previously, Mr. Scott served as the Director of Finance from January 2018 to May 2022. Mr. Scott holds a Bachelor of Science degree from the University of Minnesota - Carlson School of Management.


There is no arrangement or understanding between Mr. Scott and any other person pursuant to which Mr. Scott was selected as an officer. Mr. Scott has no family relationships with any of the Company's directors or executive officers. There are no transactions and no proposed transactions between Mr. Scott and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.